DuPont De Nemours (DD) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Apr, 2026Executive summary
Fourth quarter and full-year 2025 results exceeded guidance, driven by strong operational discipline, productivity, and portfolio transformation, including the separation of Qnity Electronics and divestiture of the Aramids business.
Organic sales growth in FY25 was led by healthcare and water end-markets, offsetting construction softness.
Executed $500 million accelerated share repurchase in Q4 2025 and set clear medium-term financial targets.
Q4 2025 GAAP loss from continuing operations was $(108) million; full year GAAP income was $98 million.
Strategic priorities for 2026 focus on above-market organic growth, business system enhancement, and balanced capital allocation.
Financial highlights
Full-year 2025 net sales were $6.8 billion, up 2% year-over-year; operating EBITDA was $1.63 billion (margin 23.8%), up 6%; adjusted EPS was $1.68, up 16% year-over-year.
Q4 2025 net sales were $1.7 billion (flat YoY); operating EBITDA was $409 million (margin 24.2%), up 4%; adjusted EPS was $0.46, up 18%.
Transaction-adjusted free cash flow for FY25 was $689 million (98% conversion); Q4 2025 was $228 million (118% conversion).
Q4 2025 cash provided by operating activities was $87 million; full year was $560 million.
Significant non-recurring items in 2025 included $203 million in acquisition, integration, and separation costs, $151 million in restructuring charges, and $114 million in debt extinguishment losses.
Outlook and guidance
2026 guidance: net sales $7.08–$7.14 billion, organic sales growth of ~3%, operating margin expansion of 60–80 basis points, adjusted EPS of $2.25–$2.30.
Free cash flow conversion expected to exceed 90%.
Q1 2026 guidance: net sales ~$1.67 billion, operating EBITDA ~$395 million, adjusted EPS ~$0.48.
Medium-term (FY25–FY28): 3–4% CAGR organic net sales, 150–200bps EBITDA margin improvement, 8–10% adjusted EPS CAGR.
Healthcare and Water expected to grow mid-single digits; Diversified Industrials to grow low single digits in 2026.
Latest events from DuPont De Nemours
- Board size reduced to ten after a director resignation; all other nominees remain.DD
Proxy filing15 Apr 2026 - Annual meeting to vote on directors, pay, auditor, and reverse stock split amid governance focus.DD
Proxy filing10 Apr 2026 - Key proposals—director elections, pay, auditor, and reverse split—recommended for approval.DD
Proxy filing10 Apr 2026 - Proxy covers director elections, executive pay, auditor ratification, and a reverse stock split.DD
Proxy filing23 Mar 2026 - Strong growth and margin gains offset by a $768M goodwill impairment charge.DD
Q1 20253 Feb 2026 - Adjusted EPS up 14% and full-year guidance raised amid electronics-driven growth.DD
Q2 20242 Feb 2026 - Q3 net sales up 4%, EBITDA up 11%, and full-year guidance raised as business separations progress.DD
Q3 202416 Jan 2026 - Strong 2024 results, margin gains, and Electronics separation set up continued 2025 growth.DD
Q4 20248 Jan 2026 - Proxy details director elections, CEO transition, and strong 2024 results with ESG focus.DD
Proxy Filing1 Dec 2025